PK Study of WD-1603 in Healthy Subjects
NCT04591535
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
8
Enrollment
INDUSTRY
Sponsor class
Conditions
Parkinson Disease
Interventions
DRUG:
WD-1603 CARBIDOPA/LEVODOPA EXTENDED-RELEASE TABLETS
Sponsor
Hong Kong WD Pharmaceutical Co., Limited